References
- Kocher AA , SchusterMD, SzabolcsMJ et al.: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.Nat. Med.7 , 430–436 (2001).
- Iwasaki H , KawamotoA, IshikawaM et al.: Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.Circulation113 , 1311–1325 (2006).
- Kawamoto A , IwasakiH, KusanoK et al.: CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.Circulation114 , 2163–2169 (2006).
- Schächinger V , AssmusB, BrittenMB et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.J. Am. Coll. Cardiol.44 , 1690–1699 (2004).
- Assmus B , HonoldJ, SchächingerV et al.: Transcoronary transplantation of progenitor cells after myocardial infarction.N. Engl. J. Med.355 , 1222–1232 (2006).
- Cangiano E , CavazzaC, CampoG et al.: Different clinical models of CD34+ cells mobilization in patients with cardiovascular disease.J. Thromb. Thrombolysis (2011) (Epub ahead of print).
References
- Kerbel RS : Tumor angiogenesis.N. Engl. J. Med.358 , 2039–2049 (2008).
- Ware JA , SimonsM: Angiogenesis in ischemic heart disease.Nat. Med.3 , 158–164 (1997).
- Yoshioka M , YuasaS, MatsumuraK et al.: Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis.Nat. Med.12 , 1151–1159 (2006).
- Bahramsoltani M , SpiegelaereWD, JanczykP, HieblB, CornillieP, PlendlJ: Quantitation of angiogenesis in vitro induced by VEGF-A and FGF-2 in two different human endothelial cultures – an all-in-one assay.Clin. Hemorheol. Microcirc.46 , 189–202 (2010).
References
- Kastl SP , SpeidlWS, KatsarosKM et al.: Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.Blood114 , 2812–2818 (2009).
- Demyanets S , KaunC, RychliK et al.: Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.Basic Res. Cardiol.106 , 217–231 (2011).
- Celletti F , WaughJ, AmabileP, BrendolanA, HilfikerP, DakeM: Vascular endothelial growth factor enhances atherosclerotic plaque progression.Nat. Med.7 , 425–429 (2001).
References
- Makino S , FukudaK, MiyoshiS et al.: Cardiomyocytes can be generated from marrow stromal cells in vitro.J. Clin. Invest.103(5) , 697–705 (1999).
- Kim SH , MoonHH, KimHA, HwangKC, LeeM, ChoiD: Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury.Mol. Ther.4(1) , 32–42 (2011).